Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx

This article originally appeared here.
Share this content:
Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx
Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx

TUESDAY, May 24, 2016 (HealthDay News) -- For patients with mantle cell lymphoma (MCL), deferred therapy seems safe and is an independent predictor of overall survival, according to a study published online May 6 in Cancer.

Jonathon B. Cohen, M.D., from Emory University in Atlanta, and colleagues examined the role of deferred therapy in MCL in a cohort of 8,029 patients. Overall, 6 percent of the patients received deferred therapy (time from diagnosis to treatment >90 days; median time to treatment, 121 days).

The researchers found that patients who deferred therapy were more likely to have stage I or II disease and extranodal involvement; they were also less likely to have B symptoms. The likelihood of being treated at a high-volume teaching/research institution was increased for deferred patients, and they were more likely to reside in the Northeast or West region. For all patients with MCL, deferred therapy was an independent predictor of overall survival. Predictors of improved overall survival among patients who deferred therapy included male sex, younger age, and a lack of comorbidities.

"Deferred therapy is a safe option for a subset of patients with MCL," the authors write. "Further study is required to better identify the best candidates for deferred therapy according to baseline risk stratification in MCL."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »